Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study

Progress in Neuro-psychopharmacology & Biological Psychiatry
Tsuyoshi MiyaokaJun Horiguchi

Abstract

Recent studies indicate that the traditional Japanese herbal medicine yi-gan san (YGS, yokukan-san in Japanese), a serotonin modulator, may be safe and useful in treating behavioral and psychological symptoms in dementia and borderline personality disorder patients. The authors examined the efficacy, tolerability, and safety of YGS in patients with tardive dyskinesia. Twenty-two patients with schizophrenia who had neuroleptic-induced tardive dyskinesia were given 7.5 g/day of YGS for 12 weeks in an open-label study. Administration of YGS resulted in a statistically significant improvement in tardive dyskinesia and psychotic symptoms. YGS may be an effective and safe therapy to control tardive dyskinesia and psychosis in patients with schizophrenia, that should be further tested in double-blind, placebo-controlled trials.

References

Jun 23, 1976·Psychopharmacology·D Goldman
Nov 1, 1976·The Journal of Nervous and Mental Disease·J J Bartko, W T Carpenter
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jun 6, 2002·Psychiatry and Clinical Neurosciences·Rika AizawaTetsuo Shimizu
Aug 31, 2004·International Journal of Epidemiology·Adrian G BarnettAnnette J Dobson
Jan 19, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tsuyoshi MiyaokaJun Horiguchi

❮ Previous
Next ❯

Citations

Apr 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Hidenori SumiyoshiShigeto Yamawaki
Nov 28, 2015·Journal of Ethnopharmacology·Yuko OgawaTenji Konishi
Aug 4, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Junzo KameiMasahiro Ohsawa
Jan 6, 2015·Psychiatry and Clinical Neurosciences·Paul P LernerVladimir Lerner
Apr 22, 2015·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Young-Ho ShimSeung-Yeon Cho
Mar 5, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Tsuyoshi MiyaokaJun Horiguchi
May 9, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Tsuyoshi MiyaokaHaruo Seno
Jul 5, 2016·Pharmacology & Therapeutics·Yasushi Ikarashi, Kazushige Mizoguchi
Jan 19, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tsuyoshi MiyaokaJun Horiguchi
May 28, 2009·Clinical Neuropharmacology·Tsuyoshi MiyaokaJun Horiguchi
Sep 3, 2010·Phytotherapy Research : PTR·S de Caires, V Steenkamp
Feb 6, 2019·Current Opinion in Psychiatry·Christian G Widschwendter, Alex Hofer
Jul 21, 2017·Expert Review of Neurotherapeutics·Stanley N CaroffBenjamin Carroll
Jul 11, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yu Jin KimBu-Yeo Kim
Jan 24, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Jung-Hee JangChangjong Moon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here